AnGes Ownership
| AMGXF Stock | USD 0.36 0.00 0.00% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
AnGes |
AnGes OTC Stock Ownership Analysis
The company has price-to-book (P/B) ratio of 0.73. Some equities with similar Price to Book (P/B) outperform the market in the long run. AnGes Inc recorded a loss per share of 0.65. The entity had not issued any dividends in recent years. AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products. AnGes, Inc. was founded in 1999 and is headquartered in Ibaraki, Japan. Anges Mg is traded on OTC Exchange in the United States.The quote for AnGes Inc is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on AnGes Inc go to https://www.anges.co.jp.Currently Active Assets on Macroaxis
Other Information on Investing in AnGes OTC Stock
AnGes financial ratios help investors to determine whether AnGes OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AnGes with respect to the benefits of owning AnGes security.